THERMO FISHER SCIENTIFIC INC. Quarterly Contract with Customer, Liability, Noncurrent in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary
Thermo Fisher Scientific Inc. quarterly Contract with Customer, Liability, Noncurrent history and growth rate from Q4 2017 to Q3 2024.
  • Thermo Fisher Scientific Inc. Contract with Customer, Liability, Noncurrent for the quarter ending September 28, 2024 was $1.43B, a 5.94% increase year-over-year.
Contract with Customer, Liability, Noncurrent, Quarterly (USD)
Contract with Customer, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.43B +$80M +5.94% Sep 28, 2024 10-Q 2024-11-01
Q2 2024 $1.46B +$357M +32.5% Jun 29, 2024 10-Q 2024-08-02
Q1 2024 $1.43B +$255M +21.8% Mar 30, 2024 10-Q 2024-05-03
Q4 2023 $1.5B +$320M +27.1% Dec 31, 2023 10-Q 2024-11-01
Q3 2023 $1.35B +$148M +12.3% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $1.1B -$139M -11.2% Jul 1, 2023 10-Q 2023-08-04
Q1 2023 $1.17B -$122M -9.43% Apr 1, 2023 10-Q 2023-05-05
Q4 2022 $1.18B -$59M -4.77% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $1.2B +$378M +46% Oct 1, 2022 10-Q 2022-11-04
Q2 2022 $1.24B +$456M +58.4% Jul 2, 2022 10-Q 2022-08-05
Q1 2022 $1.29B +$534M +70.3% Apr 2, 2022 10-Q 2022-05-06
Q4 2021 $1.24B +$475M +62.3% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $822M +$148M +22% Oct 2, 2021 10-Q 2021-11-04
Q2 2021 $781M +$157M +25.2% Jul 3, 2021 10-Q 2021-08-06
Q1 2021 $760M +$143M +23.2% Apr 3, 2021 10-Q 2021-05-07
Q4 2020 $763M +$169M +28.5% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $674M +$112M +19.9% Sep 26, 2020 10-Q 2020-10-30
Q2 2020 $624M +$92M +17.3% Jun 27, 2020 10-Q 2020-07-31
Q1 2020 $617M +$120M +24.1% Mar 28, 2020 10-Q 2020-05-01
Q4 2019 $594M +$239M +67.3% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $562M +$213M +61% Sep 28, 2019 10-Q 2019-11-01
Q2 2019 $532M +$195M +57.9% Jun 29, 2019 10-Q 2019-08-02
Q1 2019 $497M +$180M +56.8% Mar 30, 2019 10-Q 2019-05-03
Q4 2018 $355M +$33M +10.2% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $349M Sep 29, 2018 10-Q 2018-11-02
Q2 2018 $337M Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $317M Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $322M Jan 1, 2018 10-K 2019-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.